论文信息 - GSK-3 IS A POTENTIAL THERAPEUTIC TARGET FOR THE TREATMENT OF RENAL CELL CARCINOMA (RCC): PRECLINICAL IN VITRO AND IN VIVO INVESTIGATION - 字舞流文

GSK-3 IS A POTENTIAL THERAPEUTIC TARGET FOR THE TREATMENT OF RENAL CELL CARCINOMA (RCC): PRECLINICAL IN VITRO AND IN VIVO INVESTIGATION

M. Oya | V. Bilim | Y. Tomita | T. Motoyama | A. Muto | A. Ougolkov | D. Billadeau | K. Yuuki | H. Kawazoe